Journals / Türk Göğüs Kalp Damar Cerrahisi Dergisi / 2007 / Cilt: 15 - Sayı: 2

The role of positron emission tomography in mediastinal lymph node staging of non-small-cell lung cancer

Küçük hücreli dışı akciğer kanserinde mediastinal lenf nodu evrelemesinde pozitron emisyon

Pages
133–138
Publication Date
2022-09-02
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The sensitivity rates for PET and CT were found to be significantly different (p=0.004).Conclusion: Our data suggest that lymph node involvement should be evaluated with mediastinoscopy if the standardized maximum uptake value of the PET scan is greater than 2.5, and that a direct thoracotomy would not be less appropriate if an uptake value of less than 2.5 is obtained

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: Mediastinal lymph node involvement is one of the most important prognostic factors of survival in lung cancer.
📊
Key Findings & Data:Methods: The study included 53 patients (45 men, 8 women; mean age 64 years; range 49 to 75 years) who were candidates for surgery for non-small cell lung cancer and had no distant metastasis on an FDG-PET scan.
💡
Conclusion & Impact:The sensitivity rates for PET and CT were found to be significantly different (p=0.004).Conclusion: Our data suggest that lymph node involvement should be evaluated with mediastinoscopy if the standardized maximum uptake value of the PET scan is greater than 2.5, and that a direct thoracotomy would not be less appropriate if an uptake value of less than 2.5 is obtained
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background: Mediastinal lymph node involvement is one of the most important prognostic factors of survival in lung cancer. We analyzed the value of flourodeoxyglucose- positron-emission tomography (FDG-PET) in mediastinal lymph node staging of non-small-cell lung cancer. Methods: The study included 53 patients (45 men, 8 women; mean age 64 years; range 49 to 75 years) who were candidates for surgery for non-small cell lung cancer and had no distant metastasis on an FDG-PET scan. Mediastinal lymph nodes were assessed with PET and computed tomography (CT) and the results were compared in relation with histopathologic type of tumor, operations performed, lymph node dissections during thoracotomy, and histopathologic results.Results: Compared to the CT scan, PET had a higher sensitivity (66.7% vs 36.7%), positive predictive value (51.3% vs 39.3%), and negative predictive value (90.4% vs 83.5%), but a lower specificity (83.2% vs 85%) in the evaluation of mediastinal lymph nodes. The sensitivity rates for PET and CT were found to be significantly different (p=0.004).Conclusion: Our data suggest that lymph node involvement should be evaluated with mediastinoscopy if the standardized maximum uptake value of the PET scan is greater than 2.5, and that a direct thoracotomy would not be less appropriate if an uptake value of less than 2.5 is obtained

Özet

Amaç: Akciğer kanserinde sağkalımı etkileyen en önemli faktörlerden biri lenfatik tutulumdur. Bu çalışmada, küçük hücreli dışı akciğer kanserinde mediastinal lenf nodu tutulumunun değerlendirilmesinde fluorodeoksiglukoz (FDG) kullanılarak yapılan pozitron emisyon tomografisinin (FDG-PET) yeri araştırıldı. Çalışma planı: Akciğer kanseri nedeniyle ameliyata aday olan ve FDG-PET görüntülemesinde uzak metastaz saptanmayan küçük hücreli dışı akciğer karsinomlu 53 hasta (45 erkek, 8 kadın; ort. yaş 64; dağılım 49-75) çalışmaya alındı. Lenf nodlarının, PET tutulum düzeyleri ve bilgisayarlı tomografideki (BT) boyutu, tümörün histolojik tipi, yapılan ameliyatlar ve çıkarılan mediastinal lenf nodları ve patoloji sonuçları değerlendirildi.Bulgular: Mediastinal lenf nodlarının değerlendirilmesinde PET görüntülemenin duyarlılığı %66.7, özgüllüğü %83.2, pozitif öngördürücü değeri %51.3, negatif öngördürücü değeri %90.4 bulunurken, aynı değerler BT’de sırasıyla %36.7, %85, %39.3 ve %83.5 idi. Pozitron emisyon tomografisi ile BT arasında duyarlılık açısından fark istatistiksel olarak anlamlı idi (p=0.004).Sonuç: Pozitron emisyon tomografisinde maksimum standardize tutulum değerinin 2.5’in üzerinde olduğu durumlarda lenf nodu tutulumunun mediastinoskopiyle değerlendirilmesi gerektiği, 2.5’in altında olduğu durumlarda ise torakotomi yapılmasının yanlış bir yaklaşım olmayacağı sonucuna varıldı.

🔖

Cite This Article

ZİYADE, S., DİLEGE, Ş., KALAYCI, G., TANJU, S., EROĞLU, O., TOKER, A. (2022). The role of positron emission tomography in mediastinal lymph node staging of non-small-cell lung cancer. Türk Göğüs Kalp Damar Cerrahisi Dergisi, Cilt: 15 - Sayı: 2, 133–138. https://ajindex.com/articles/425116

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Boring CC, Squires TS, Tong T. Cancer statistics, 1992. CA Cancer J Clin 1992;42:19-38
  2. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin 1997;47:5-27
  3. Huang SC, Phelps ME, Hoffman EJ, Sideris K, Selin CJ, Kuhl DE. Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol 1980;238:E69-82
  4. Mortelmans L, Vanhaecke J, Lesaffre E, Arnold A, Urbain JL, Hermens W, et al. Evaluation of the effect of thrombolytic treatment on infarct size and left ventricular function by enzymatic, scintigraphic, and angiographic methods. The European Cooperative Study Group for Recombinant Tissue Type Plasminogen Activator. Am Heart J 1990;119:1231-7
  5. Mortelmans L, Nuyts J, Scheys I, Wackers F, Lesaffre E, Brzostek T, et al. A new quantitative method for the analysis of cardiac perfusion tomography (SPET): validation in postinfarct patients treated with thrombolytic therapy. Eur J Nucl Med 1993;20:1193-200
  6. Vansteenkiste JF. Imaging in lung cancer: positron emission tomography scan. Eur Respir J Suppl 2002;35:49-60
  7. Scott WJ, Gobar LS, Terry JD, Dewan NA, Sunderland JJ. Mediastinal lymph node staging of non-small-cell lung cancer: a prospective comparison of computed tomography and positron emission tomography. J Thorac Cardiovasc Surg 1996;111:642-8
  8. Steinert HC, Hauser M, Allemann F, Engel H, Berthold T, von Schulthess GK, et al. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology 1997;202:441-6
  9. Wahl RL, Quint LE, Greenough RL, Meyer CR, White RI, Orringer MB. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology 1994;191:371-7
  10. Dwamena BA, Sonnad SS, Angobaldo JO, Wahl RL. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s-meta-analytic comparison of PET and CT. Radiology 1999;213:530-6
  11. Sazon DA, Santiago SM, Soo Hoo GW, Khonsary A, Brown C, Mandelkern M, et al. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer. Am J Respir Crit Care Med 1996;153:417-21
  12. Cerfolio RJ, Ojha B, Bryant AS, Bass CS, Bartalucci AA, Mountz JM. The role of FDG-PET scan in staging patients with nonsmall cell carcinoma. Ann Thorac Surg 2003;76:861-6
  13. Gonzalez-Stawinski GV, Lemaire A, Merchant F, O’Halloran E, Coleman RE, Harpole DH, et al. A comparative analysis of positron emissi